| Drug Name |
Antihemophilic factor (recombinant) |
| Drug ID |
BADD_D00147 |
| Description |
Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells |
| Indications and Usage |
For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency. |
| Marketing Status |
Not Available |
| ATC Code |
B02BD02 |
| DrugBank ID |
DB00025
|
| KEGG ID |
D05401
|
| MeSH ID |
C078147
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
0944-3054; 0026-3787; 68982-139; 58394-015; 0026-3828; 68982-143; 58394-025; 0944-3045; 0944-3051; 0944-3047; 0026-3824; 0944-3053; 58394-013; 0026-3826; 68982-151; 68982-153; 0026-3782; 0026-3783; 0944-3046; 58394-023; 0026-3786; 58394-024; 0026-3785; 68982-145; 68982-141; 0026-3822; 68982-147; 0026-3821; 58394-014; 58394-012; 58394-016; 58394-022; 68982-149; 0944-3052 |
| Synonyms |
F8 protein, human | antihemophilic factor human | factor VIII, human | coagulation factor VIII, human | coagulation factor VIII, procoagulant component (hemophilia A) protein, human | FVIII protein, human | BAY 81-8973 | F8B protein, human | Bioclate | Hemofil | Hemofil M | Hemophil | Hemofil HM | Kogenate FS | Kogenate | Monoclate | Recombinate | xyntha | Kovaltry | octocog alfa | Humate-P |
